NDC 49288-0127

Canary Feather

Canary Feather

Canary Feather is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Serinus Canaria Feather.

• Product ID: 49288-0127_f08d6882-f5d5-4109-b9df-64c85e82a0a1
• NDC: 49288-0127
• Product Type: Human Prescription Drug
• Proprietary Name: Canary Feather
• Generic Name: Canary Feather
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1974-03-23
• Marketing Category: BLA / BLA
• Application Number: BLA102223
• Labeler Name: Antigen Laboratories, Inc.
• Substance Name: SERINUS CANARIA FEATHER
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Non-Standardized Feather Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Feathers [CS],Allergens [CS]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 49288-0127-5

50 mL in 1 VIAL, MULTI-DOSE (49288-0127-5)

• Marketing Start Date: 1974-03-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 49288-0127-3 [49288012703]

Canary Feather INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0127-1 [49288012701]

Canary Feather INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0127-5 [49288012705]

Canary Feather INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0127-2 [49288012702]

Canary Feather INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

NDC 49288-0127-4 [49288012704]

Canary Feather INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102223
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1974-03-23
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
SERINUS CANARIA FEATHER	.02 g/mL

OpenFDA Data

• SPL SET ID: 960c58a9-572e-41c5-8e0e-7ad1ff955030
• Manufacturer:
  • Antigen Laboratories, Inc.
• UNII:
  • TOQ97Z8644
  • 16M9MK8C4W
  • 83B65P4796
  • 05S7L91ZTR
  • 9EL3384IQY
  • 1FCM16V0FV
  • KBA5Y6X57N
  • 09N62XQ70Y
  • 15XI414745
  • 4F35XG0149
  • C27W02JU62
  • 7Q7T9Z7QUW
• RxNorm Concept Unique ID - RxCUI:
  • 895535
  • 895513
  • 894964
  • 894940
  • 895524
  • 895506
  • 894786
  • 895547
  • 895541
  • 895545
  • 895530
  • 895518
  • 895520
  • 894937
  • 895491
  • 895500
  • 895493
  • 895510
  • 895502
  • 892854
  • 895498

Pharmacological Class

• Non-Standardized Feather Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Increased IgG Production [PE]
• Feathers [CS]
• Allergens [CS]